Corporate
-
-
-
-
Janssen Therapeutics Announces Funding in Support of Improved Retention in Care and Access to Treatment for Blacks and African Americans Living with HIV in Southern United States and other Rural Areas
Award Funding Extends Company’s Ongoing Commitment to Supporting Underserved Communities in the United States -
Mental Distress May Have a Greater Impact on Quality of Life Than Chronic Illnesses
A Johnson & Johnson Health and Wellness Solutions study shows managing mental wellness is critical to improve quality of life in patients with chronic illness -
Johnson & Johnson Advances Commitment to Improve Global Health and Well-Being
A New Commitment to 2030 Sustainable Development Goals and Ongoing Support for Refugees -
Johnson & Johnson Announces Agreement to Acquire Abbott Medical Optics
Acquisition to Strengthen Global Leadership in Eye Health Adding Cataract and Refractive Eye Surgery to Vision Care Portfolio -
Johnson & Johnson Announces Ruling Related to REMICADE® in the District of Massachusetts Federal Court Hearing
Johnson & Johnson (NYSE: JNJ) today announced that the District of Massachusetts Federal Court has issued a ruling on a summary judgment motion filed by Celltrion Healthcare Co. Ltd. and Celltrion Inc -
Johnson & Johnson Announces Completion of Acquisition of Vogue International LLC
Acquisition Strengthens Position in Hair Care